ProfileGDS5678 / 1459124_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 58% 59% 59% 57% 58% 64% 59% 63% 59% 58% 63% 58% 58% 62% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.5365858
GSM967853U87-EV human glioblastoma xenograft - Control 23.521959
GSM967854U87-EV human glioblastoma xenograft - Control 33.5269959
GSM967855U87-EV human glioblastoma xenograft - Control 43.3815357
GSM967856U87-EV human glioblastoma xenograft - Control 53.4388158
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.8911664
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.6497359
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.7715263
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.5088659
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4890858
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.7696263
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4592858
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.519458
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.7144262